摘要
目的探讨临床药师对经皮冠状动脉介入治疗(PCI)术后患者的药学监护,为心内科临床药师开展药学服务提供参考。方法临床药师对1例PCI术后患者反复出现支架内再狭窄的因素进行分析,分别从抗血小板药物治疗的基因多态性、术后血脂和血糖的控制、用药依从性教育和出院后电话随访等方面提出建议并进行药学监护。结果与结论临床药师为临床医师对该患者药物治疗方案的调整提供了合理的建议并对其实施药学监护,半年后电话回访未出现心血管不良事件和药物不良反应,为其安全有效地用药提供保障,并提高用药依从性。
Objective To provide reference for clinical pharmacists in cardiovascular department about pharmaceutical services by studying pharmaceutical care for one patient after percutaneous coronary interven- tion （PCI）. Methods Clinical pharmacist analyzed possible factors that might affect repeated in -stent restenosis （ISR） in a patients after PCI and provided suggestions including polymorphism of anti - platelet drugs, therapy of regulating glycemla and lipidemia, patient＇ s compliance with medication, and telephone follow up after discharge. Results and conclusion The clinical pharmacist gave rational advices about adjust- ment of therapy, provided pharmaceutical care on this patient and found that adverse cardiovascular event and adverse drug reaction didnt appear again when calling back after 6 months, thus ensuring the safety and effi- ciency of drug use and improving patients＂ compliance.
出处
《中国临床药理学杂志》
CAS
CSCD
北大核心
2017年第9期832-834,共3页
The Chinese Journal of Clinical Pharmacology
基金
国家自然科学基金资助项目(81173132)
关键词
经皮冠脉动脉介入治疗
支架内再狭窄
药学监护
临床药师
percutaneous coronary intervention
in - stent restenosis
pharmaceutical care
clinical pharmacist
